Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2114 Significance of Biochemical Testing in Pancreatic Neuroendocrine Tumors
Introduction: Pancreatic neuroendocrine tumors (PNETs) are rare tumors that are frequently diagnosed late in the course of the disease. Several biomarkers have been proposed in the literature for diagnosis in patients with these tumors.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Athar A,
Keywords: Biochemical markers, PNETs, Better prognosis,
Introduction: No study has yet assessed the utility of biochemical biomarkers for evaluating NET burden using 68Ga-DOTATATE PET/CT.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Tirosh A, Papadakis G, Millo C, Sadowski S, Herscovitch P,
Keywords: PET burden,
Introduction: New clinical prognostic tools are needed in order to select patients with NETs that are at higher risk of DSM. Biochemical biomarker DT is used clinically for prognosis prediction in several solid malignancies
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Tirosh A
Authors: Tirosh A, Nilubol N, Patel D, Kebebew E,
Keywords: doubling time, biomarker, prognosis,
#899 Evaluation of the Clinical Utility of Plasma Biomarkers in Diagnosis of Neuroendocrine Tumors
Introduction: Neuroendocrine tumors (NETs) are rare cancers that usually develop in the gastroenterohepatic system. Diagnostic workup of these tumors includes measurement of plasma levels of marker peptides. Clinical experience suggests that these markers may be misleading if used before histological or imaging evidence of a NET is available.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Lunberg-Adams M
Authors: Lunberg-Adams M, James A, Perros P,
Keywords: chromogranin A, neurokinin A, pancreatic polypeptide, neuroendocrine tumor diagnosis,
#713 Non-Functioning Pancreatic Neuroendocrine Tumors (PNET): Association with Prediabetes/Diabetes
Introduction: Neuroendocrine tumors of pancreas (PNET) are classified as functional or nonfunctional (NF) based on presence or absence of clinical syndrome associated with hormone over secretion. NF-PNETs do, however, often produce low levels of inactive hormones (pancreatic polypeptide, calcitonin or neurotensin) which do not cause any symptoms.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Osher E
Authors: Osher E, Greenman Y, Tordjman K, Sofer Y, Scapa E,